Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

What I Saw at the Pandemic

Philip Seo, MD, MHS  |  Issue: December 2020  |  December 14, 2020


Dr. SeoPhilip Seo, MD, MHS, is an associate professor of medicine at the Johns Hopkins University School of Medicine, Baltimore. He is director of both the Johns Hopkins Vasculitis Center and the Johns Hopkins Rheumatology Fellowship Program.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Notes

Some of you may have noticed that in March 2020, The Rheumatologist took a hard turn. That’s when I realized SARS-CoV-2 wasn’t going to quietly disappear, as had MERS and SARS-CoV-1, and I decided that our coverage should reflect this new, unwelcome visitor to our lives. We decided early on that we could best serve our readership by becoming a place where you could tell your stories. By my count, we have published more than 130 stories related to COVID-19, and we will continue to tell your stories about how COVID-19 has affected your lives until it is no longer necessary, inshallah.

This rapid change of direction was ably assisted by my associate editors, Vicky Ruffing, RN-BC, and Ethan Craig, MD, MHS, who helped create a vision for the type of coverage of the pandemic we wanted to provide. For those of you who miss some of our regular features, be assured that we plan to weave them more expertly with our COVID-19 coverage in the next calendar year, so there will be something for everyone.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Also, I would be remiss if I did not thank Keri Losavio, who is the actual editor of The Rheumatologist, and is responsible for making the trains run on time. I am particularly pleased to note that Wiley, the publisher of The Rheumatologist, has rewarded her hard work with a well-deserved promotion to Custom Content Editor II. In announcing her promotion, the publisher noted, “[d]uring the past six years at Wiley, Keri has been instrumental in expanding The Rheumatologist’s editorial footprint … to help grow the brand.” Truer words never spoken.

One final anecdote: A colleague recently reminded me of the words of Jonathan Mann, who helped mobilize the global response against HIV/AIDS: “Our responsibility is historic, for when the history of … the global response is written, our most precious contribution may well be that at the time of plague, we did not flee; we did not hide; and we did not separate.” Those words now apply to each one of us, in a way that none of us could have possibly imagined at the beginning of this year.

I expect that 2020 will not leave quietly. I predict more than our share of misery lies ahead, but I am hopeful for a brighter future in 2021. Until that time, I place a charge on you: Be kind to one another. Be generous. Be forgiving. This has been a rough year. But, as Thomas Fuller wrote, “It is always darkest just before the day dawneth.”9 And the dawn is in sight.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:COVID-19

Related Articles

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

    Research Helps Explain Idiosyncrasies of COVID-19

    November 23, 2021

    The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.

    Bernard Chantal / shutterstock.com

    Diagnostic Challenges of MIS-C

    May 12, 2022

    During the peak of the coronavirus pandemic in Washington, D.C., we were asked to evaluate a 14-year-old boy admitted to the pediatric hospitalist service. He had been healthy until two weeks before, when he noted a sore throat, and soon after he developed fevers and rashes without congestion, shortness of breath, conjunctivitis or swollen lymph…

    Serological Antibody Tests in COVID-19: Test Reliability and Utility

    June 10, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences